Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
9.43%
Grew
—
—
Shrank
—
1 Year
Score—
Net Growth9.43%
Net TrendGrew
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
5 Years
—
21.79%
60%
—
—
20%
—
5 Years
Score—
Net Growth21.79%
Net Trend60%
Net Income Consistency—
Rev Growth—
Rev Trend20%
Revenue Consistency—
Zentalis Pharmaceuticals Llc fundamental performance
Across Zentalis Pharmaceuticals Llc's full reported history, from 2020 to 2025, revenue held from $ 0.00 to $ 0.00 and net income went from -$ 117M to -$ 137M. Revenue increased in 17% of the years measured; net income in 50%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 4.29 | — |
1 Year2025-08-12 | $ 1.41 | 204.26% |
5 Years2021-08-12 | $ 50.19 | -91.45% |
All Time2020-04-03 | $ 23.20 | -81.51% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2020-04-03 |
|---|---|---|---|---|
| Price | $ 4.29 | $ 1.41 | $ 50.19 | $ 23.20 |
| Return | — | 204.26% | -91.45% | -81.51% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 0.00 | -$ 124M | $ 211M |
| 2025 | $ 0.00 | -$ 137M | $ 245M |
| 2024 | $ 67M | -$ 165M | $ 371M |
| 2023 | $ 0.00 | -$ 292M | $ 482M |
| 2022 | $ 0.00 | -$ 236M | $ 437M |
| 2021 | $ 0.00 | -$ 158M | $ 340M |
| IPO2020 | $ 0.00 | -$ 117M | $ 338M |
Explore beyond ZNTL
You're looking at Zentalis Pharmaceuticals Llc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
